Roche Diagnostics Launches Next-Generation Sequencer "AXELIOS 1" Utilizing Proprietary SBX Technology – A Crucial First Step Towards Future Genomic Medicine Deployment
Roche Diagnostics K.K. (Headquarters: Minato-ku, Tokyo; President and CEO: Kei Maeda; hereinafter re… · 2026-07-01